Relapsing Cytokine Release Syndrome in a Patient with Metastatic Renal Cell Carcinoma Treated with Pembrolizumab and Axitinib Therapy
INTERNATIONAL CANCER CONFERENCE JOURNAL（2024）
Key words
Renal cell carcinoma,Immune checkpoint inhibitor,Immune-related adverse event,Cytokine release syndrome
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined